Bile duct cancers are a tough bunch to beat. They are tricky because they come in different forms and are hard to treat. For a long time, doctors have used a combo of gemcitabine and cisplatin to help patients feel better, even if it couldn't cure them. This was the go-to treatment for over ten years. But now, things are changing. Two big studies, TOPAZ-1 and KEYNOTE...
Bile duct cancer, also known as biliary tract carcinoma, is a tough nut to crack. It is a serious disease that has not seen many breakthroughs in treatment. It is not all doom and gloom, though. Researchers have been testing out different ways to fight this disease. They have been looking at combining different types of treatments to see if they can improve the o...
Some cancer treatments are causing unexpected problems. These treatments are designed to fight cancer. However, they also increase the risk of heart attacks and strokes in patients. It is hard to understand exactly why this happens. One possible reason is that these treatments speed up the hardening of arteries. This is due to increased inflammation in the body. ...
The immune system usually fights off illnesses. But when it comes to liver cancer, it faces a tough opponent. This type of cancer, known as hepatocellular carcinoma, is tricky. It often goes undetected until it's too late. This makes it hard to treat with standard methods. However, there's a new tool in the fight against liver cancer: immune checkpoint inhibitors, or...
Cancer is a massive health problem around the world. One major breakthrough in fighting cancer is a type of treatment called immune checkpoint inhibitors. These treatments help the body's immune system fight cancer by blocking certain proteins. These proteins are like brakes on the immune system. By releasing these brakes, the immune system can attack cancer cell...
In the world of cancer treatment, immune checkpoint inhibitors (ICIs) have become a big deal. They help the immune system fight cancer. But they might also cause some trouble. One such issue is uveitis, an inflammation of the eye. The question is: do ICIs really increase the risk of uveitis? This is what researchers wanted to find out. They compared ICIs with chemot...
Cancer treatment has seen a big change with immune checkpoint inhibitors (ICIs). These drugs help the body's immune system fight cancer. But, some patients see their cancer grow quickly. This is called hyperprogressive disease (HPD). It's a big problem for doctors and patients. It's important to understand why this happens. ICIs work by blocking certain pro...
Hepatocellular carcinoma (HCC) is a type of liver cancer that is notoriously tough to treat. Doctors have been experimenting with immune checkpoint inhibitors (ICIs) to fight this disease. However, these drugs can sometimes make the cancer grow faster, a condition known as hyperprogressive disease (HPD). This is bad news for patients, as it means the cancer is gettin...
Pleural mesothelioma (PM) is a tough cancer to treat. It's caused by asbestos exposure, and it's not easy to cure. Doctors have been looking for better ways to fight this disease. Recently, they have found some promising results with immune checkpoint inhibitors (ICIs). ICIs are a type of drug that helps the body's immune system recognize and attack cancer cells. ...
Treatment options for epithelial ovarian cancer (EOC) have expanded a lot in recent years, but much of the progress has been tied to picking the right biomarkers. This means there's still a big need for better treatment options to help patients live longer and enjoy better quality of life. Unlike many other types of cancer, using immune checkpoint inhibitors (CPIs) a...